Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells
替莫唑胺联合天然来源的 AT101 序贯治疗作为替代治疗策略：深入了解存活胶质母细胞瘤细胞的化学耐药机制
期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms24109075
Dana Hellmold, Carolin Kubelt, Tina Daunke, Silje Beckinger, Ottmar Janssen, Margarethe Hauck, Fabian Schütt, Rainer Adelung, Ralph Lucius, Jochen Haag, Susanne Sebens, Michael Synowitz, Janka Held-Feindt
